Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Development of a Cascade of Care for responding to the opioid epidemic
Arthur Robin Williams, Edward V. Nunes, Adam Bisaga, et al.
The American Journal of Drug and Alcohol Abuse (2019) Vol. 45, Iss. 1, pp. 1-10
Open Access | Times Cited: 271

Showing 1-25 of 271 citing articles:

Responding to the opioid crisis in North America and beyond: recommendations of the Stanford–Lancet Commission
Keith Humphreys, Chelsea L. Shover, Christina M. Andrews, et al.
The Lancet (2022) Vol. 399, Iss. 10324, pp. 555-604
Open Access | Times Cited: 308
Worldwide rates of diagnosis and effective treatment for cystic fibrosis
Jonathan Guo, Anna Garratt, Andrew Hill
Journal of Cystic Fibrosis (2022) Vol. 21, Iss. 3, pp. 456-462
Open Access | Times Cited: 222
Improving Access to Evidence-Based Medical Treatment for Opioid Use Disorder: Strategies to Address Key Barriers Within the Treatment System
Bertha K. Madras, N. Jia Ahmad, Jenny Wen, et al.
NAM Perspectives (2020)
Open Access | Times Cited: 188
Acute Care, Prescription Opioid Use, and Overdose Following Discontinuation of Long-Term Buprenorphine Treatment for Opioid Use Disorder
Arthur Robin Williams, Hillary Samples, Stephen Crystal, et al.
American Journal of Psychiatry (2019) Vol. 177, Iss. 2, pp. 117-124
Open Access | Times Cited: 170
Opioid agonist treatment and fatal overdose risk in a state‐wide US population receiving opioid use disorder services
Noa Krawczyk, Ramin Mojtabai, Elizabeth A. Stuart, et al.
Addiction (2020) Vol. 115, Iss. 9, pp. 1683-1694
Open Access | Times Cited: 140
Barriers and Facilitators to Clinician Readiness to Provide Emergency Department–Initiated Buprenorphine
Kathryn Hawk, Gail D’Onofrio, Marek C. Chawarski, et al.
JAMA Network Open (2020) Vol. 3, Iss. 5, pp. e204561-e204561
Open Access | Times Cited: 139
Receipt of Telehealth Services, Receipt and Retention of Medications for Opioid Use Disorder, and Medically Treated Overdose Among Medicare Beneficiaries Before and During the COVID-19 Pandemic
Christopher M. Jones, Carla Shoff, Kevin Hodges, et al.
JAMA Psychiatry (2022) Vol. 79, Iss. 10, pp. 981-981
Open Access | Times Cited: 103
Racial/ethnic disparities in opioid overdose prevention: comparison of the naloxone care cascade in White, Latinx, and Black people who use opioids in New York City
Maria R. Khan, Lee Ann Hoff, Luther Elliott, et al.
Harm Reduction Journal (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 56
Emergency Clinician Buprenorphine Initiation, Subsequent Prescriptions, and Continuous Prescriptions
Annette M. Dekker, David L. Schriger, Andrew A. Herring, et al.
JAMA (2025)
Closed Access | Times Cited: 1
Stigma and substance use disorders: A clinical, research, and advocacy agenda.
Valerie A. Earnshaw
American Psychologist (2020) Vol. 75, Iss. 9, pp. 1300-1311
Open Access | Times Cited: 121
Who stays in medication treatment for opioid use disorder? A national study of outpatient specialty treatment settings
Noa Krawczyk, Arthur Robin Williams, Brendan Saloner, et al.
Journal of Substance Abuse Treatment (2021) Vol. 126, pp. 108329-108329
Open Access | Times Cited: 95
America’s opioid crisis: the need for an integrated public health approach
Carlos Blanco, Tisha Wiley, Jacqueline J. Lloyd, et al.
Translational Psychiatry (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 92
Consensus Recommendations on the Treatment of Opioid Use Disorder in the Emergency Department
Kathryn Hawk, Jason Hoppe, Eric Ketcham, et al.
Annals of Emergency Medicine (2021) Vol. 78, Iss. 3, pp. 434-442
Open Access | Times Cited: 84
Targeting Youth to Prevent Later Substance Use Disorder: An Underutilized Response to the US Opioid Crisis
Wilson M. Compton, Christopher M. Jones, Grant Baldwin, et al.
American Journal of Public Health (2019) Vol. 109, Iss. S3, pp. S185-S189
Open Access | Times Cited: 83
Addressing Racial And Ethnic Disparities In The Use Of Medications For Opioid Use Disorder
Barbara Andraka‐Christou
Health Affairs (2021) Vol. 40, Iss. 6, pp. 920-927
Closed Access | Times Cited: 77
Pharmacy-related buprenorphine access barriers: An audit of pharmacies in counties with a high opioid overdose burden
Neda J. Kazerouni, Adriane N. Irwin, Ximena A. Levander, et al.
Drug and Alcohol Dependence (2021) Vol. 224, pp. 108729-108729
Closed Access | Times Cited: 70
Management of Infective Endocarditis in People Who Inject Drugs: A Scientific Statement From the American Heart Association
Larry M. Baddour, Melissa B. Weimer, Alysse G. Wurcel, et al.
Circulation (2022) Vol. 146, Iss. 14
Open Access | Times Cited: 61
Targeting the Barriers in the Substance Use Disorder Continuum of Care With Peer Recovery Support
Milena Stanojlović, Larry Davidson
Substance Abuse Research and Treatment (2021) Vol. 15
Open Access | Times Cited: 55
“In their mind, they always felt less than”: The role of peers in shifting stigma as a barrier to opioid use disorder treatment retention
Morgan S. Anvari, Mary B. Kleinman, Ebonie Massey, et al.
Journal of Substance Abuse Treatment (2022) Vol. 138, pp. 108721-108721
Open Access | Times Cited: 41
Perspectives About Emergency Department Care Encounters Among Adults With Opioid Use Disorder
Kathryn Hawk, Ryan McCormack, E. Jennifer Edelman, et al.
JAMA Network Open (2022) Vol. 5, Iss. 1, pp. e2144955-e2144955
Open Access | Times Cited: 38
Association of Receipt of Opioid Use Disorder–Related Telehealth Services and Medications for Opioid Use Disorder With Fatal Drug Overdoses Among Medicare Beneficiaries Before and During the COVID-19 Pandemic
Christopher M. Jones, Carla Shoff, Carlos Blanco, et al.
JAMA Psychiatry (2023) Vol. 80, Iss. 5, pp. 508-508
Open Access | Times Cited: 23
Transitions in care between hospital and community settings for individuals with a substance use disorder: A systematic review
Hannah James, Jeffrey Morgan, Lianping Ti, et al.
Drug and Alcohol Dependence (2023) Vol. 243, pp. 109763-109763
Closed Access | Times Cited: 22
Prioritized Research for the Prevention, Treatment, and Reversal of Chronic Disease: Recommendations From the Lifestyle Medicine Research Summit
Yoram Vodovotz, Neal D. Barnard, Frank B. Hu, et al.
Frontiers in Medicine (2020) Vol. 7
Open Access | Times Cited: 59
Epidemiology of the U.S. opioid crisis: the importance of the vector
Wilson M. Compton, Christopher M. Jones
Annals of the New York Academy of Sciences (2019) Vol. 1451, Iss. 1, pp. 130-143
Open Access | Times Cited: 58
Remote Methods for Conducting Tobacco-Focused Clinical Trials
Jennifer Dahne, Rachel L. Tomko, Erin A. McClure, et al.
Nicotine & Tobacco Research (2020) Vol. 22, Iss. 12, pp. 2134-2140
Open Access | Times Cited: 54
Page 1 - Next Page

Scroll to top